Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

GROOVE BOTANICALS INC. (GRVE) Form 10-Q — Aug 10, 2026

$GRVEForm 10-QFiled Aug 10, 2026, 6:07 PM ET0001477932-26-004834Original filing

Groove Botanicals, Inc. filed its 10-Q for the quarter ended June 30, 2026 reporting zero revenue, a net loss of $21,171 (improved from $38,170 a year earlier), and just $1,494 of cash against total liabilities of roughly $1.55 million. The filing carries explicit going-concern doubt, with an accumulated deficit of $35.6 million and a stockholders' deficit of $1.54 million. Operations are funded by advances from CEO Kent Rodriguez, who is owed $774,140 in accrued compensation and advances, while $710,028 of preferred dividends sit accrued and unpaid.

Key figures

Eps
-0.00
Revenue
0
Total Assets
2525
Cash Position
1494
Shares Outstanding
59643062
Monthly rent
1200
Total liabilities
1546562
Ceo monthly salary
4000
Accumulated deficit
35630757
Related party payable
774140
Anticipated capital needs
$500,000 to $5,000,000
Auditor settlement income
7147
Quarterly preferred dividends
54618
Series a liquidation preference
500000
Accrued unpaid preferred dividends
710028
Series a accrued dividends outstanding
130000
Series b accrued dividends outstanding
580028

AI analysis

Red flags7 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    GROOVE BOTANICALS INC. (GRVE) Form 10-Q — Aug 10, 2026: AI Analysis | Signal8